- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 2.03M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 930.67K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 659 sh |
| Capex | Q1 2026 · Mar 31, 2026 | $22K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.86M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$5.56M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $629K |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $9.09M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $10.74M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.32M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.63M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $20.99M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.79M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $27.47M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $12.79M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $18.9M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $16.98M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $80.16M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $22.74M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$6.81 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.17 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$6.81 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.17 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $85K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $144K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.2M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.7M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.62M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.4M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $7.46M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $3.38M |
| Revenue | Q1 2026 · Mar 31, 2026 | $9.86M |
| Revenue | Q1 2026 · Mar 31, 2025 | $3.7M |